Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Serina Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 33 | 33 | 0 |
| Shares | 4.79M | 4.78M | −5.57K (−0.1%) |
| Value | $4.09M | $2.75M | −$1.34M (−32.7%) |
New holders (5)
Institutions that held Serina Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 24,565 | $14.0K | 0.00% |
| Citadel Advisors LLC | 16,017 | $9.00K | 0.00% |
| LPL Financial LLC | 13,043 | $8.00K | 0.00% |
| Two Sigma Securities, LLC | 10,875 | $6.00K | 0.00% |
| CoreCap Advisors, LLC | 10 | $0 | 0.00% |
Sold out (5)
Institutions that held Serina Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Defender Capital, LLC. | 34,090 | $29.0K |
| Susquehanna International Group, LLP | 14,790 | $13.0K |
| FMR LLC | 5,350 | $5.00K |
| Citigroup Inc | 2,571 | $2.00K |
| CWM, LLC | 200 | $0 |